Fuzuloparib
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Fuzuloparib, covering 2023-04-19 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib [Phase 2]